PROTIER Biotech Inc.
PrivateLast Round
Early Funding
Mar 31, 2026
Total Funding Raised
$2.45M
Company Overview
PROTIER Biotech Inc. is a biotechnology company that develops targeted protein degradation therapeutics and molecular glue platforms for the treatment of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
targeted protein degradationTPDmolecular glueprotein degradersoncology drug discoveryantibody-drug conjugatesADCsmall-molecule drugsdrug licensingbiotech R&Dprotein degradation therapeuticstargeted therapynext-gen oncologydrug pipeline
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PROTIER Biotech Inc. Comparables
Compare PROTIER Biotech Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| UBITAS Biotech | 86% | |
| Magnet Biomedicine | 86% | |
| Proxygen | 84% | |
PROTIER Biotech Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Mar 31, 2026 | ||||
| Accelerator | Mar 26, 2026 | ||||
| Seed | Jun 1, 2024 |
PROTIER Biotech Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hana Ventures | Early Funding |
| Korea Investment Accelerator | Early Funding |
| IBK Venture Investment | Early Funding |
| Mirae Science and Technology Holdings | Early Funding |
| T Investment | Early Funding |
PROTIER Biotech Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about PROTIER Biotech Inc.'s valuation, stock price, and market status.